Reasons Juno Therapeutics Is The Biotech Of The Year
Xconomy doesn’t have annual awards (the X-ies, anyone?), but I don’t have any hesitation naming Juno Therapeutics (NASDAQ: JUNO) the biotech company of the year for 2014. This is neither a prediction of future success nor an endorsement. Rather, it’s an acknowledgment that hands-down, Juno was the most atypical biotech I’ve seen in years, perhaps ever.
Hey, check out all the research scientist jobs. Post your resume today!
Hey, check out all the research scientist jobs. Post your resume today!